Cargando…

Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy

Background: Few studies focused on the relationship between the albumin-to-alkaline phosphatase ratio (AAPR) and the urologic outcomes in patients with non-metastatic renal cell carcinoma (RCC) following curative surgery. The aim of this study was to evaluate the prognostic value of preoperative AAP...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Aidan, Chen, Yuming, Chen, Jingfeng, Pan, Yue, Bao, Lianmin, Gao, Xiaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775680/
https://www.ncbi.nlm.nih.gov/pubmed/31632493
http://dx.doi.org/10.7150/jca.34029
_version_ 1783456299910955008
author Xia, Aidan
Chen, Yuming
Chen, Jingfeng
Pan, Yue
Bao, Lianmin
Gao, Xiaomin
author_facet Xia, Aidan
Chen, Yuming
Chen, Jingfeng
Pan, Yue
Bao, Lianmin
Gao, Xiaomin
author_sort Xia, Aidan
collection PubMed
description Background: Few studies focused on the relationship between the albumin-to-alkaline phosphatase ratio (AAPR) and the urologic outcomes in patients with non-metastatic renal cell carcinoma (RCC) following curative surgery. The aim of this study was to evaluate the prognostic value of preoperative AAPR in non-metastatic RCC patients. Methods: The prognostic value of AAPR was evaluated in a primary cohort with 419 non-metastatic RCC patients following curative radical or partial nephrectomy and then further validated in an independent cohort consisting of 204 patients. A nomogram was developed based on the independent predictors, and its predictive value was assessed. Results: Kaplan-Meier survival analysis demonstrated that patients with low AAPR levels were significantly associated with worse overall survival (OS) and cancer-specific survival (CSS) compared with patients with high AAPR levels both in two cohorts. Univariate and multivariate analyses revealed that low AAPR was an independent risk factor for OS (HR = 2.745; 95%CI, 1.266-5.953; P = 0.011) and CSS (HR = 3.042; 95%CI, 1.278-7.243; P = 0.012). Moreover, subgroup analysis (Fuhrman grade G1+G2 and Fuhrman grade G3+G4; T1+T2 stage and T3+T4 stage) revealed that low AAPR was also related to worse urological outcomes. Although no significant differences between patients with low AAPR and patients with high AAPR can be observed with regard to CSS under Fuhrman grade G1+G2 (P=0.058) and T1+T2 stage (P=0.318), there was a worse CSS trend in low AAPR patients. The established nomograms for OS and CSS were well calibrated and had moderate discriminative ability (concordance index: 0.821 and 0.839, respectively) Conclusions: Preoperative AAPR might be an independent prognostic factor in patients with non-metastatic RCC. The ratio should be applied in RCC patients for risk stratification and clinical decision-making.
format Online
Article
Text
id pubmed-6775680
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-67756802019-10-18 Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy Xia, Aidan Chen, Yuming Chen, Jingfeng Pan, Yue Bao, Lianmin Gao, Xiaomin J Cancer Research Paper Background: Few studies focused on the relationship between the albumin-to-alkaline phosphatase ratio (AAPR) and the urologic outcomes in patients with non-metastatic renal cell carcinoma (RCC) following curative surgery. The aim of this study was to evaluate the prognostic value of preoperative AAPR in non-metastatic RCC patients. Methods: The prognostic value of AAPR was evaluated in a primary cohort with 419 non-metastatic RCC patients following curative radical or partial nephrectomy and then further validated in an independent cohort consisting of 204 patients. A nomogram was developed based on the independent predictors, and its predictive value was assessed. Results: Kaplan-Meier survival analysis demonstrated that patients with low AAPR levels were significantly associated with worse overall survival (OS) and cancer-specific survival (CSS) compared with patients with high AAPR levels both in two cohorts. Univariate and multivariate analyses revealed that low AAPR was an independent risk factor for OS (HR = 2.745; 95%CI, 1.266-5.953; P = 0.011) and CSS (HR = 3.042; 95%CI, 1.278-7.243; P = 0.012). Moreover, subgroup analysis (Fuhrman grade G1+G2 and Fuhrman grade G3+G4; T1+T2 stage and T3+T4 stage) revealed that low AAPR was also related to worse urological outcomes. Although no significant differences between patients with low AAPR and patients with high AAPR can be observed with regard to CSS under Fuhrman grade G1+G2 (P=0.058) and T1+T2 stage (P=0.318), there was a worse CSS trend in low AAPR patients. The established nomograms for OS and CSS were well calibrated and had moderate discriminative ability (concordance index: 0.821 and 0.839, respectively) Conclusions: Preoperative AAPR might be an independent prognostic factor in patients with non-metastatic RCC. The ratio should be applied in RCC patients for risk stratification and clinical decision-making. Ivyspring International Publisher 2019-08-29 /pmc/articles/PMC6775680/ /pubmed/31632493 http://dx.doi.org/10.7150/jca.34029 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Xia, Aidan
Chen, Yuming
Chen, Jingfeng
Pan, Yue
Bao, Lianmin
Gao, Xiaomin
Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy
title Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy
title_full Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy
title_fullStr Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy
title_full_unstemmed Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy
title_short Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy
title_sort prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775680/
https://www.ncbi.nlm.nih.gov/pubmed/31632493
http://dx.doi.org/10.7150/jca.34029
work_keys_str_mv AT xiaaidan prognosticvalueofthealbumintoalkalinephosphataseratioonurologicoutcomesinpatientswithnonmetastaticrenalcellcarcinomafollowingcurativenephrectomy
AT chenyuming prognosticvalueofthealbumintoalkalinephosphataseratioonurologicoutcomesinpatientswithnonmetastaticrenalcellcarcinomafollowingcurativenephrectomy
AT chenjingfeng prognosticvalueofthealbumintoalkalinephosphataseratioonurologicoutcomesinpatientswithnonmetastaticrenalcellcarcinomafollowingcurativenephrectomy
AT panyue prognosticvalueofthealbumintoalkalinephosphataseratioonurologicoutcomesinpatientswithnonmetastaticrenalcellcarcinomafollowingcurativenephrectomy
AT baolianmin prognosticvalueofthealbumintoalkalinephosphataseratioonurologicoutcomesinpatientswithnonmetastaticrenalcellcarcinomafollowingcurativenephrectomy
AT gaoxiaomin prognosticvalueofthealbumintoalkalinephosphataseratioonurologicoutcomesinpatientswithnonmetastaticrenalcellcarcinomafollowingcurativenephrectomy